Membranous nephropathy is more likely to recur.
As a pathological type of nephropathy, membranous nephropathy is characterized by severe condition, difficult treatment and high recurrence rate.
Pre-treatment of membranous nephropathy requires hormones and cytotoxic drugs to cooperate with each other, such as the combined use of glucocorticoids and cyclophosphamide. Recently, it is also treated with rituximab, which has also achieved better results. Generally, the treatment cycle is about 2 years, after the completion of the treatment cycle, patients need to review the blood, urine and other relevant indicators every 3-6 months to assess the condition.
Membranous nephropathy is prone to recurrence and requires lifelong monitoring. It is recommended that patients with membranous nephropathy should follow the doctor’s instructions to take medication regularly, review their condition on time, control their daily diet, ensure a reasonable work and rest schedule, and exercise appropriately to reduce the recurrence rate.
Patients with membranous nephropathy are advised to consult regular hospitals and follow the doctor’s instructions for standardized treatment, do not use medication on your own.